Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Macrolide; protein synthesis inhibitor. ≥3900...
Nucleoside (deoxyadenosine) analog found in Co...
Endogenous tachykinin peptide, involved in infl...
Specific inhibitor of histone methyltransferase...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Zinc chelator
GnRH analog; GnRH1 agonist.
FGFR inhibitor.
MAO and histone demethylase LSD1 inhibitor.
Triterpene saponin found in species of Panax.
JNK, ALK, p38 MAPK inhibitor.
Nucleotide analog; RT inhibitor.
B-Raf and c-Raf inhibitor.
Tripeptide, binds cell surface integrins.
RIP1 inhibitor.
Polypeptide; peptidoglycan inhibitor.
Neuropeptide hormone found in arthropods.
Active metabolite of losartan
β-lactam; transpeptidase inhibitor.
Diarylheptanoid found in Zingiberaceae.